Nonalcoholic steatohepatitis (NASH) promotes fibrotic remodeling of the liver parenchyma, which may lead to cirrhosis, liver failure, or hepatocellular carcinoma. Gd-EOB-DTPA is a hepatobiliary T1 MRI contrast agent, receiving increasing attention as a tool for detecting and staging liver fibrosis. Here, using a choline-deficient high-fat diet (CDAHFD) for different durations we modeled NASH disease progression in rats and performed Gd-EOB-DTPA-enhanced MRI at different disease stages, correlating imaging histological measures of fibrosis as well as liver function tests. Gd-EOB-DTPA-enhanced MRI correlated well with liver function tests but not with liver fibrosis.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords